The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program. This systematic review synthesised all available English-language guidelines and research regarding mass-vaccination for COVID-19 until 1 March 2021—the first three months of the global mass-vaccination effort. Data were extracted from national websites, PubMed, Embase, Medline and medRxiv, including peer and non-peer review research findings. A total of 15 national policy documents were included. Policies were summarised according to the World Health Organisation (WHO) framework for mass vaccination. All included policies prioritised front-line health care workers and the elderly. Limited information was available regarding staffing, cold chain, communication strategies and infrastructure requirements for effective vaccine delivery. A total of 26 research studies were identified, reporting roll-out strategies, vaccine uptake and reasons for refusal, adverse effects, and real-life estimates of efficacy. Early data showed a reduction in SARS-CoV-2 cases, hospitalisation and deaths in settings with good coverage. Very low rates of vaccine-related serious adverse events were observed. These findings provide an overview of current practice and early outcomes of COVID-19 mass-vaccination, guiding countries where roll-out is yet to commence.
【저자키워드】 vaccination, COVID, implementation, national policy data, 【초록키워드】 COVID-19, SARS-CoV-2, Efficacy, Vaccine, Europe, systematic review, outcome, Policy, adverse effects, Coverage, Research, death, Health care worker, WHO, estimate, information, hospitalisation, Middle East, Serious Adverse Event, World Health Organisation, North America, effort, National, refusal, vaccinate, research findings, country, effective, reduction in, Limited, synthesised, 【제목키워드】 review, Strategy, guideline,